Class IIDrug
Chlorthalidone Tablets recall
Summary
Inventia Healthcare Limited is recalling Chlorthalidone Tablets (drug). According to the FDA report, the reason is: Failed Dissolution Specifications. The FDA rated this a Class II: the product may cause temporary or medically reversible health problems; serious harm is unlikely. Recall status: Ongoing.
Details from the FDA report
- Product
- Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01
- Reason
- Failed Dissolution Specifications
- Lot / code info
- Batch # RISA24002; Exp Date: 04/2027
- Quantity
- 13567 bottles
- Distribution
- U.S. Nationwide
- Recalling company
- Inventia Healthcare Limited, Kalyan, N/A India
- Recall started
- September 3, 2026
- FDA report date
- September 23, 2026
- Classification
- Class II: The product may cause temporary or medically reversible health problems; serious harm is unlikely.
- Voluntary / mandated
- Voluntary: Firm initiated
- Status
- Ongoing
- Recall number
- D-0852-2026
What to do
- Check whether you have this product, and compare the lot numbers, codes, or dates on your package with the codes listed above.
- If it matches, stop using it and keep it away from children and pets.
- Contact the recalling company (Inventia Healthcare Limited) or the store where you bought it about returns or refunds.
- Do not stop a prescribed medication without first talking to your pharmacist or doctor; they can help find a safe replacement.
- If you think the product made you or someone else sick, contact a doctor or pharmacist. In an emergency call 911.
- You can report problems to the FDA via MedWatch.